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Methods: A total of 97 Pseudomonas aeruginosa strains
were isolated from various clinical specimens at the Kuala
Lumpur Hospital, Malaysia between October and December
2007. Antimicrobial susceptibility was determined using the
E-test method subsequent to the hospital’s routine diagnos-
tic testing by the disk diffusion (DD) method. Results were
interpreted according to the Clinical and Laboratory Stan-
dards Institute (CLSI) guidelines.
Results: Total agreement of DD and E-test methods
was 99% for susceptibility to gentamicin, ciproﬂoxacin
and ceftazidime, 98% for susceptibility to amikacin,
piperacillin/tazobactam, imipenem and meropenem and
97% for susceptibility to cefepime. According to the
E-test method, the rates of susceptible isolates were
piperacillin/tazobactam 91%, amikacin 87%, gentamicin
85%, ciproﬂoxacin 84%, ceftazidime and cefepime 80% each,
imipenem 79% and meropenem 77%. 24% of the isolates were
resistant to two or more antimicrobial agents.
Conclusion: The E-test and DD methods showed high
agreement in determining the in vitro activity of the
antimicrobial agents on the Pseudomonas aeruginosa iso-
lates. Although the DD method is more cost effective for
routine hospital use, the E-test is rapid, easy to per-
form and has an added ability to determine MIC value.
Piperacillin/tazobactam was the most active antimicrobial
agent in vitro against Pseudomonas aeruginosa, followed
by the aminoglycosides (amikacin and gentamicin). By con-
trast, the quinolone (ciproﬂoxacin) and the beta-lactams
(meropenem, imipenem, cefepime and ceftazidime)were
the least active antimicrobial agents. Periodical surveillance
study of such provides very useful data on the overall situa-
tion in a hospital.
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Background: AmpC class beta lactamases are
cephalosporinases that are poorly inhibited by clavu-
lanic acid. They are different from other ESBLs by their
ability to hydrolyze Cephamycins (cefoxitin,cefotetan)
in addition to other extended spectrum cephalosporins.
Plasmid mediated Amp C beta lactamases differ from
chromosomal AmpCs in being uninducible and are typically
associated with broad multi drug resistance. Information on
the prevalence of AmpC beta lactamase producing strains
from India is scanty.
Here in we report a study done on gram negative bacilli
for AmpC detection using the previously reported AmpC disk
test from a tertiary public health care centre of North India.
Methods: The strains of gram negative bacilli included
42 Klebsiella pneumoniae, 2 Klebsiella oxytoca, 6 Proteus
mirabilis, 100 Salmonella typhi and 39 E. coli. Resistance to
cefoxitin was ﬁrst seen determined by disc diffusion test.
Only cefoxitin resistant isolates were further processed for
AmpC detection by the method of Amp C disc test. Positive
results were read as any indentation or ﬂattening of the
zone of inhibition. All the strains were also simultaneously
checked for ESBL production.
Results: Cefoxitin resistance was not detected in any
strain of Salmonella. Out of remaining 50 isolates exclud-
ing E. coli, Amp C was detected in 15 isolates-13 Klebsiella
pneumoniae, 1 Klebsiella oxytoca and 1 Proteus mirabilis.
10 showed indentation and 5 showed ﬂattening of the
zones. All the isolates were sensitive to Imipenem and vari-
ably sensitive to ciproﬂoxacin, cefoperazone-sulbactam and
aminoglycosides. Also regarding E. coli isolates 15 out of 39
showed AmpC disc test positivity.
Conclusion: 15/50 i.e (30%) of the Klebsiella pneumo-
niae, Klebsiella oxytoca, and Proteus mirabilis showed
prescence of AmpC from our centre, which is most proba-
bly plasmid mediated as these organisms lack chromosomal
AmpC. As regards E. coli, percentage positivity is about 45%,
but these could be plasmid or chromosomal.
doi:10.1016/j.ijid.2008.05.301
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Background: Pseudomonas aeruginosa, recognized as
human opportunistic pathogen is increasingly responsible
for lethal nosocomial infections. Treatment options are dra-
matically declining worldwide. This species has emerged as
a relevant animal pathogen too. This is a consequence of
massive antibiotic use and the large versatile genome of
this organism. Antimicrobial proﬁling of P. aeruginosa ani-
mal isolates may contribute to a better understanding of the
development and the epidemiology of P. aeruginosa multi-
drug resistance in our densely populated biosphere with
increasing human-animal interactions.
Methods: This work characterized 66 P. aeruginosa
clinical isolates originating from diverse animals (horses,
cows, sea turtles, dolphins, cats, parrots, canguru,
etc.) using amongst others fAFLP (ﬂuorescent Ampliﬁed
Fragment Length Polymorphisms) ﬁngerprinting. Suscepti-
bility to 21 antibiotics (amikacin, amoxicillin/clavulanic
acid, ampicillin, chloranfenicol, carbenicillin, ceftazidime,
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cefoperazone, ciproﬂoxacin, cephalexin, gentamicin, cefo-
taxime, enroﬂoxacin, imipinem, nalidixic acid, oﬂoxacin,
penicillin G, piperacillin, streptomicin, sulphametoxa-
zole/trimethroprim, tetracycline and tobramicin) was
evaluated by the VITEK system (Biomérieux). Antibiotic-
resistance gene detection was performed by Multiplex-PCR.
The ﬁngerprinted animal isolates were evaluated on there
clonality and pasted into the global population structure
of P. aeruginosa. All data were analysed by biological data
analysis software (Bionumerics, AppliedMaths).
Results: Antimicrobial-resistance traits were similar
amongst all isolates, showing high degrees of resistance.
None was susceptible to all antimicrobial compounds while
most possessed multi-resistance proﬁles. Comparison of the
genomic and phenotypic Antibiotic-Resistance results where
highly concordant. Most isolates clustered into successful
clonal complexes, including human epidemic strains. No
animal strains however clustered into the spreading MDR-
O12-clone although several strains clustered among the
CF-clones.
Conclusion: In a constantly evolving world, medical epi-
demiology should strive for a broader perspective, consisting
of a global approach including bacteria from humans, the
environment and animals from different geographical loca-
tions at different time-points.
doi:10.1016/j.ijid.2008.05.302
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Objectives: To determinate the frequency Gram-
negative bacteria of pathogens isolated from patients
with bacteraemia and to investigate their susceptibility
patterns.
Material and Methods: The blood cultures were incu-
bated in Bactec 9120 system (Becton Dickinson) in aerobic
plus, anaerobic plus and mycosis vials. All the positive cul-
tures were Gram strained and re-cultured in blood agar, Mac
Conkey agar and Chromagar candida (Becton Dickinson). The
protocol for negative blood cultures included a seven days
period. The infections were characterized as nosocomial
accorting to CDC criteria. Identiﬁcation of microorganisms
and susceptibility test was performed out with the Vitek
2 system (BioMerieux, France), the susceptibility disc dif-
fusion method according to CLSI directions and the E-test
method (Solna, Sweden).
Results: A total of 2519 blood cultures were screened
for aerobic, anaerobic and fungi, during a two year
period (January 2006 - December 2007). Bacteraemia was
detected in 350 ICU and 132 NICU patients. Of the 482
pathogens from ICU and NICU, Gram-positive bacteria were
the predominant isolates (n = 244, 50.62%), followed by
Gram-negative (n = 231, 47.93%) and fungi (n = 7, 1.45%).
Gram-negative bacteria more frequently isolated from
ICU and NICU were: Acinetobacter baumanii 49/9, Kleb-
siella pneumoniae 46/8, Pseudomonas aeruginosa 36/8,
Enterobacter cloasae 37/4, Escherichia coli 9/10. The resis-
tance rates (%) of Acinetobacter baumanii from ICU and
NICU were: amikacin 87/86, gentamicin70/57, imipenem
80/29, meropenem 34/25, piperacillin/tazobactam 84/67,
ampicillin/sulbactam46/20, colistin 0/0. The resistance
rates (%) of Pseudomonas aeruginosa were: ceftazidime
69/25, ciproﬂoxacin 72/25, amikacin 48/25, aztreonam
91/17, piperacillin/tazobactam 48/38, imipenem 69/0,
meropenem 71/0, colistin 0/0. The resistance rates
(%) of Klebsiella pneumoniae were: amikacin 33/25,
gentamicin 32/25, ciproﬂoxacin 5/50, imipenem 80/50,
piperacillin/tazobactam 67/50, colistin 0/0.
Conclusion: A very high incidence of multidrug resistant
Gram-negative strains causing bacteraemia were isolated
especially from ICU patients. There is necessary to limit the
overuse of antibiotics and implementation of a new antibi-
otic policy.
doi:10.1016/j.ijid.2008.05.303
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Background: Antibiotic resistance of Shigella spp. has
increased recently and varies with geographic distribution.
The empirical antibiotic therapy in each region would need
to be updated accordingly.
Methods: Anti-microbial susceptibilities of Shigella iso-
lates collected in a central laboratory in southern Taiwan
were examined by the disc diffusion method. Epidemiolog-
ically related cases were classiﬁed as cases of an outbreak
event. Only one isolate for each episodic case or outbreak
event was included for analysis.
Results: From 2001 to 2007, 47 Shigella isolates including
25 S. ﬂexneri, 2 S. boydii and 20 S. sonnei were ana-
lyzed. All were susceptible to ciproﬂoxacin and with varied
resistance to other antibiotics: 6.4% to cefotaxime, 51.1%
to ampicillin, 63.8% to trimethoprim -sulfamethoxazole,
and 38.3% to chloramphenicol. Resistance to cefotaxime
emerged since 2006, whereas resistance trends to other
antibiotics were unchanged signiﬁcantly in the past
7 years.
Conclusion: Continued monitoring of Shigella isolates to
detect the emergence of resistance is essential, especially
resistance to the 3rd generation cephalosporin.
doi:10.1016/j.ijid.2008.05.304
